The store will not work correctly when cookies are disabled.
1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl nitrate
ID: ALA3763669
PubChem CID: 9837337
Max Phase: Preclinical
Molecular Formula: C9H18N2O4
Molecular Weight: 218.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)CC(O[N+](=O)[O-])CC(C)(C)N1O
Standard InChI: InChI=1S/C9H18N2O4/c1-8(2)5-7(15-11(13)14)6-9(3,4)10(8)12/h7,12H,5-6H2,1-4H3
Standard InChI Key: DHHTZVHCRMTEHV-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 15 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3238 -0.1256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2708 -1.9497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0531 2.0753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0530 2.0754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6331 -3.6060 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5548 -3.6021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
4 7 1 0
5 8 1 0
5 9 1 0
3 10 1 0
3 11 1 0
1 12 1 0
12 13 1 0
13 14 2 0
13 15 1 0
M CHG 2 13 1 15 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 218.25 | Molecular Weight (Monoisotopic): 218.1267 | AlogP: 1.61 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.84 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.64 | CX LogP: 0.84 | CX LogD: 0.84 |
Aromatic Rings: ┄ | Heavy Atoms: 15 | QED Weighted: 0.56 | Np Likeness Score: -0.07 |
References
1. Acharya S, Rogers P, Krishnamoorthy RR, Stankowska DL, Dias HV, Yorio T.. (2016) Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy., 26 (5): [PMID:26832784] [10.1016/j.bmcl.2015.12.030] |